erlotinib hydrochloride has been researched along with carbocyanines in 2 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (carbocyanines) | Trials (carbocyanines) | Recent Studies (post-2010) (carbocyanines) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 5,287 | 4 | 2,147 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heath, JR; Johnson, D; Su, Y; Wei, W; Xue, M | 1 |
| Chen, H; Gao, Y; Jia, L; Li, F; Li, Z; Lv, T; Xie, X; Zhang, H; Zhang, L; Zhang, Y | 1 |
2 other study(ies) available for erlotinib hydrochloride and carbocyanines
| Article | Year |
|---|---|
Supramolecular Probes for Assessing Glutamine Uptake Enable Semi-Quantitative Metabolic Models in Single Cells.
Topics: Brain Neoplasms; Carbocyanines; Cell Line, Tumor; Dose-Response Relationship, Drug; ErbB Receptors; Erlotinib Hydrochloride; Fluorescence Resonance Energy Transfer; Glioblastoma; Glutamine; Humans; Molecular Probes | 2016 |
Erlotinib-Guided Self-Assembled Trifunctional Click Nanotheranostics for Distinguishing Druggable Mutations and Synergistic Therapy of Nonsmall Cell Lung Cancer.
Topics: Administration, Intravenous; Animals; Antineoplastic Combined Chemotherapy Protocols; Carbocyanines; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Click Chemistry; Copper; Drug Liberation; Drug Resistance, Neoplasm; Drug Synergism; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Infrared Rays; Lung Neoplasms; Mice; Mice, Nude; Microscopy, Confocal; Microscopy, Fluorescence; Molecular Targeted Therapy; Mutation; Photochemotherapy; Theranostic Nanomedicine; Xenograft Model Antitumor Assays | 2018 |